New drug LB-P8 aims to tame rare liver disease PSC
NCT ID NCT06699121
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug, LB-P8, in 87 adults with primary sclerosing cholangitis (PSC), a rare liver disease. The goal is to see if LB-P8 is safe and can lower levels of alkaline phosphatase (ALP), a marker of liver damage. Participants will receive either LB-P8 or a placebo, and researchers will monitor side effects and changes in liver health over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY SCLEROSING CHOLANGITIS (PSC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Liver institute Northwest
RECRUITINGSeattle, Washington, 98105, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mayo Clinic
NOT_YET_RECRUITINGRochester, Minnesota, 55905, United States
Contact
Contact Phone: •••-•••-••••
-
Mercy Medical Center
RECRUITINGBaltimore, Maryland, 21202, United States
Contact Phone: •••-•••-••••
Contact
-
The Vanderbilt Clinic
RECRUITINGNashville, Tennessee, 37232, United States
Contact
Contact Phone: •••-•••-••••
-
UCHealth University of Colorado Hospital
NOT_YET_RECRUITINGAurora, Colorado, 80045, United States
Contact
Contact Phone: •••-•••-••••
-
University Of Iowa Hospitals And Clinics
RECRUITINGIowa City, Iowa, 52242, United States
Contact
Contact Phone: •••-•••-••••
-
University of California Davis
NOT_YET_RECRUITINGSacramento, California, 95817, United States
Contact
Contact Phone: •••-•••-••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One pill may tame both itchy skin and stubborn liver disease
- Could a common antibiotic ease Kids' bowel disease?
- New biodegradable stents offer hope for PSC patients
- Poop pills could tame rare liver disease
- Old antibiotic, new hope? vancomycin trial for UC and PSC
- New pill shows promise for rare liver disease